Jill Henrich's most recent trade in Atara Biotherapeutics Inc was a trade of 1,059 Common Stock done at an average price of $7.0 . Disclosure was reported to the exchange on March 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Atara Biotherapeutics Inc | Jill Henrich | EVP, Chief Regulatory Officer | Sale of securities on an exchange or to another person at price $ 7.00 per share. | 03 Mar 2025 | 1,059 | 18,679 (0%) | 0% | 7.0 | 7,410 | Common Stock |
| Atara Biotherapeutics Inc | Jill Henrich | EVP, Chief Regulatory Officer | 18 Nov 2024 | 1,000 | 19,378 (0%) | 0% | 11.2 | 11,198 | Common Stock | |
| Atara Biotherapeutics Inc | Jill Henrich | EVP, Global Head RA & Quality | 16 Aug 2024 | 831 | 20,510 (0%) | 0% | 6.6 | 5,509 | Common Stock | |
| Atara Biotherapeutics Inc | Jill Henrich | EVP, Global Head RA & Quality | 16 Aug 2024 | 132 | 20,378 (0%) | 0% | 6.6 | 875 | Common Stock | |
| Atara Biotherapeutics Inc | Jill Henrich | EVP, Global Head RA & Quality | 16 May 2024 | 25,750 | 529,251 (0%) | 0% | 0.6 | 15,888 | Common Stock | |
| Atara Biotherapeutics Inc | Jill Henrich | EVP, Global Head RA & Quality | 04 Mar 2024 | 3,879 | 555,001 (0%) | 0% | 0.7 | 2,793 | Common Stock | |
| Atara Biotherapeutics Inc | Jill Henrich | EVP, Global Head RA & Quality | 08 Jan 2024 | 450,000 | 558,880 (0%) | 0% | 0 | Common Stock |